[Percutaneous endoscopic gastrostomy: cost/benefit analysis in patients with carcinoma of the upper aero-digestive tract]

Bull Cancer. 2000 Apr;87(4):329-33.
[Article in French]

Abstract

The aim of this retrospective study was to evaluate the cost and benefit of percutaneous fluoroscopic gastrostomy feeding (PFG) in 70 cancer patients with advanced stage disease of the upper-aero digestive tract; we retrospectively analyzed the consequences in terms of nutritional status (evaluated by weight and body mass index), the possibility to lead a treatment by high dose chemo-radiotherapy to the end of the therapeutic schedule, the feasibility, complications and cost ratios. Three weeks after the procedure, no major complication was observed, the initial nutritional threshold was conserved. PFG is a safe and effective technique; the additional cost is low (2%) compared with the total cost of hospitalization.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / radiotherapy
  • Cost-Benefit Analysis
  • Esophageal Neoplasms / complications*
  • Esophageal Neoplasms / drug therapy
  • Esophageal Neoplasms / radiotherapy
  • Feasibility Studies
  • Gastroscopy / adverse effects
  • Gastroscopy / economics*
  • Gastroscopy / methods
  • Humans
  • Hypopharyngeal Neoplasms / complications*
  • Hypopharyngeal Neoplasms / drug therapy
  • Hypopharyngeal Neoplasms / radiotherapy
  • Middle Aged
  • Nutrition Disorders / therapy*
  • Nutritional Status
  • Parenteral Nutrition / adverse effects
  • Parenteral Nutrition / economics*
  • Parenteral Nutrition / methods
  • Radiography, Interventional / adverse effects
  • Radiography, Interventional / economics
  • Retrospective Studies